Related Experiment Video
Updated: Jul 31, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Parvimonas micra a new potential pathogen in hospitalized patients: a case series from 2015-2022
Daniele Piccinini1, Enos Bernasconi1,2, Mattia Carelli3
1Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Abstract:
Parvimonas micra isolations are usually part of polymicrobial infections and the pathogenic role of this microrganism is still debated. We describe here a large series of hospitalized patients diagnosed with Parvimonas micra infections and discuss the clinical and therapeutic management and the outcome of these infections.
Insights
Parvimonas micra infections are often polymicrobial, with its pathogenic role debated. This study details clinical management and outcomes for hospitalized patients with Parvimonas micra infections.
Area of Science:
- Microbiology
- Infectious Diseases
Background:
- Parvimonas micra is often found in polymicrobial infections.
- The specific pathogenic role of Parvimonas micra remains unclear.
Purpose of the Study:
- To describe a series of hospitalized patients with Parvimonas micra infections.
- To discuss the clinical and therapeutic management of these infections.
- To analyze the outcomes of Parvimonas micra infections.
Main Methods:
- Retrospective case series analysis.
- Inclusion of hospitalized patients diagnosed with Parvimonas micra infections.
- Review of clinical data, treatment strategies, and patient outcomes.
Main Results:
- Characterization of Parvimonas micra infection demographics and clinical presentations.
- Analysis of various treatment approaches and their effectiveness.
- Evaluation of patient outcomes, including recovery and complications.
Conclusions:
- Parvimonas micra can be a significant pathogen in hospitalized patients.
- Effective clinical and therapeutic management strategies are crucial for favorable outcomes.
- Further research is needed to fully elucidate the pathogenic potential of Parvimonas micra.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: